Back to Browse Journals » International Journal of Chronic Obstructive Pulmonary Disease » Volume 8

The search for common pathways underlying asthma and COPD

Authors Kaneko Y, Yatagai Y, Yamada H, Iijima H, Masuko H, Sakamoto T, Hizawa N

Published Date January 2013 Volume 2013:8 Pages 65—78

DOI http://dx.doi.org/10.2147/COPD.S39617

Received 26 October 2012, Accepted 8 December 2012, Published 25 January 2013

Yoshiko Kaneko, Yohei Yatagai, Hideyasu Yamada, Hiroki Iijima, Hironori Masuko, Tohru Sakamoto, Nobuyuki Hizawa

Department of Pulmonary Medicine, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan

Abstract: Recently, several genes and genetic loci associated with both asthma and chronic obstructive pulmonary disease (COPD) have been described as common susceptibility factors for the two diseases. In complex diseases such as asthma and COPD, a large number of molecular and cellular components may interact through complex networks involving gene–gene and gene–environment interactions. We sought to understand the functional and regulatory pathways that play central roles in the pathobiology of asthma and COPD and to understand the overlap between these pathways. We searched the PubMed database up to September 2012 to identify genes found to be associated with asthma, COPD, tuberculosis, or essential hypertension in at least two independent reports of candidate-gene associations or in genome-wide studies. To learn how the identified genes interact with each other and other cellular proteins, we conducted pathway-based analysis using Ingenuity Pathway Analysis software. We identified 108 genes and 58 genes that were significantly associated with asthma and COPD in at least two independent studies, respectively. These susceptibility genes were grouped into networks based on functional annotation: 12 (for asthma) and eleven (for COPD) networks were identified. Analysis of the networks for overlap between the two diseases revealed that the networks form a single complex network with 229 overlapping molecules. These overlapping molecules are significantly involved in canonical pathways including the “aryl hydrocarbon receptor signaling,” “role of cytokines in mediating communication between immune cells,” “glucocorticoid receptor signaling,” and “IL-12 signaling and production in macrophages” pathways. The Jaccard similarity index for the comparison between asthma and COPD was 0.81 for the network-level comparison, and the odds ratio was 3.62 (P < 0.0001) for the asthma/COPD pair in comparison with the tuberculosis/ essential hypertension pair. In conclusion, although the identification of asthma and COPD networks is still far from complete, these networks may be used as frameworks for integrating other genome-scale information including expression profiling and phenotypic analysis. Network overlap between asthma and COPD may indicate significant overlap between the pathobiology of these two diseases, which are thought to be genetically related.

Keywords: COPD, asthma, network, common pathways, aryl hydrocarbon receptor signaling

Download Article [PDF] View Full Text [HTML] 

Creative Commons License This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution - Non Commercial (unported, v3.0) License. The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. Permissions beyond the scope of the License are administered by Dove Medical Press Limited. Information on how to request permission may be found at: http://www.dovepress.com/permissions.php

Other article by this author:

Readers of this article also read:

The clue of a possible etiology about spontaneous regression of hepatocellular carcinoma: a perspective on pathology

Wang Z, Ke ZF, Lu XF, Luo CJ, Liu YD, Lin ZW, Wang LT

OncoTargets and Therapy 2015, 8:395-400

Published Date: 5 February 2015

COPD: balancing oxidants and antioxidants

Fischer BM, Voynow JA, Ghio AJ

International Journal of Chronic Obstructive Pulmonary Disease 2015, 10:261-276

Published Date: 2 February 2015

Cardiovascular and inflammatory effects of simvastatin therapy in patients with COPD: a randomized controlled trial

John ME, Cockcroft JR, McKeever TM, Coward WR, Shale DJ, Johnson SR, Thornton JG, Harrison TW, Knox AJ, Bolton CE

International Journal of Chronic Obstructive Pulmonary Disease 2015, 10:211-221

Published Date: 29 January 2015

The development of individual cognitive stimulation therapy (iCST) for dementia

Yates LA, Leung P, Orgeta V, Spector A, Orrell M

Clinical Interventions in Aging 2015, 10:95-104

Published Date: 30 December 2014

Silica-coated flexible liposomes as a nanohybrid delivery system for enhanced oral bioavailability of curcumin

Li C, Zhang Y, Su T, Feng L, Long Y, Chen Z

International Journal of Nanomedicine 2012, 7:5995-6002

Published Date: 5 December 2012

Rindopepimut: an evidence-based review of its therapeutic potential in the treatment of EGFRvIII-positive glioblastoma

Babu R, Adamson DC

Core Evidence 2012, 7:93-103

Published Date: 14 September 2012

Metabolic pathway and distribution of superparamagnetic iron oxide nanoparticles: in vivo study

Schlachter EK, Widmer HR, Bregy A, Lönnfors-Weitzel T, Vajtai I, Corazza N, Bernau VJP, Weitzel T, Mordasini P, Slotboom J, Herrmann G, Bogni S, Hofmann H, Frenz M, Reinert M

International Journal of Nanomedicine 2011, 6:1793-1800

Published Date: 26 August 2011

Corrigendum: Softec HD hydrophilic acrylic intraocular lens: biocompatibility and precision

Espandar L, Sikder S, Moshirfar M

Clinical Ophthalmology 2011, 5:159-160

Published Date: 6 February 2011